Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Table 64 Therapeutic protocols used in intervention and comparison groups in included studies<br />
focusing on the use of HBOT in head and neck cancer.*<br />
First Author and Year of<br />
Publication Intervention Group Comparison Group<br />
Whittle 1990 99 n=157<br />
Placement in a monoplace HBO chamber at 3<br />
ATA up to one hour, plus concurrent<br />
radiotherapy at a dose of 32-34 Gy in six<br />
fractions over 18 days.<br />
Henk 1986 100 n=54<br />
Placement in a HBOT chamber, pressure and<br />
time not stated. Dosage and fractionation<br />
scheme for radiotherapy was 3600-4500 rad in<br />
10 fractions in 22 days.<br />
Sealy 1986 101 n=64<br />
Radiotherapy in HBOT. Radiotherapy dose of<br />
36.0 Gy in six fractions over 17 days.<br />
Misonidazole (2.0g/m2 p.o. per fraction) was<br />
also prescribed and HBOT at 3 ATA.<br />
Berry 1979 102 n=9<br />
Radiotherapy concurrent with HBOT; dose of<br />
radiotherapy was 4000-4500 rad (reduced to<br />
3650-4150 rad in the larynx was involved) in<br />
10 fractions.<br />
Sause 1979 103 n=21<br />
Radiation therapy: 12 х 400 rad in 32 days<br />
during concurrent HBOT at 3 ATA.<br />
Chang 1973 104 n=26<br />
Radiotherapy at a dose of 600 rad x 6<br />
treatments (two per week for three weeks),<br />
concurrently with HBOT at 3 ATA.<br />
Churchill-Davidson<br />
1973 105<br />
n=102<br />
HBOT at 3-4 ATA with radiotherapy at a<br />
maximum dose of 3600 rads in six fractions<br />
over 18-19 days.<br />
Shigamatsu 1973 106 n=21<br />
Radiotherapy concurrent with HBOT at 3 ATA<br />
in a monoplace chamber. Radiotherapy<br />
consisted of a total dose of 6000-7000 R in a<br />
bi-weekly schedule.<br />
Henk 1970 107 n=101<br />
Radiotherapy received concurrent to HBOT at<br />
3 ATA in a monoplace chamber. Radiotherapy<br />
at a dose of 3500-4500 rads in 10 fractions<br />
over three weeks.<br />
* Abbreviations: ATA = atmosphere absolute, n = sample size<br />
† <strong>Therapy</strong> not described.<br />
n=240<br />
Conventional radiotherapy in air at a dose<br />
of 60-70 Gy, five fractions per week.<br />
n=53<br />
Conventional radiotherapy in air: 30<br />
fractions over six weeks; dosage received<br />
was 6400 rad (proportionally smaller<br />
when fields were larger).<br />
n=66<br />
Conventional radiotherapy in air: tumour<br />
dose of 63.0 Gy in 30 fractions daily over<br />
38 days.<br />
n=15<br />
Conventional radiotherapy in air: 4450-<br />
5000 rad in 15 fractions or 4850-5500 rad<br />
in 20 fractions depending on field size.<br />
n=23<br />
Conventional radiotherapy (250-6250 rad)<br />
in air.<br />
n=25<br />
Control group 1: n=12 received<br />
radiotherapy in air at a dose of 600 rads<br />
per treatment for seven treatments (two<br />
per week for 3.5 weeks).<br />
Control group 2: n=13 received<br />
radiotherapy at 200 rads per treatment for<br />
30 treatments (five per week for six<br />
weeks).<br />
n=69<br />
Radiotherapy treatment in air. †<br />
n=21<br />
Radiotherapy in air, 4000-5000 R in 9-10<br />
fractions.<br />
n=112<br />
Radiotherapy in air: 3500-4500 rads in 10<br />
equal fractions, over three weeks.<br />
The disparities in intervention protocols were reflected in equally varied comparison<br />
protocols. Doses and fractionation schemes varied between the intervention and<br />
<strong>Hyperbaric</strong> oxygen therapy 65